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Abstract
Background: The mammalian target of rapamycin (mTOR) is a regulator of cell proliferation, cell growth and
apoptosis working through two distinct complexes: mTORC1 and mTORC2. Although much is known about the
activation and inactivation of mTORC1, the processes controlling mTORC2 remain poorly characterized. Experimental
and modeling studies have attempted to explain the regulation of mTORC2 but have yielded several conflicting
hypotheses. More specifically, the Phosphoinositide 3-kinase (PI3K) pathway was shown to be involved in this process,
but the identity of the kinase interacting with and regulating mTORC2 remains to be determined (Cybulski and Hall,
Trends Biochem Sci 34:620-7, 2009).
Method: We performed a literature search and identified 5 published hypotheses describing mTORC2 regulation.
Based on these hypotheses, we built logical models, not only for each single hypothesis but also for all combinations
and possible mechanisms among them. Based on data provided by the original studies, a systematic analysis of all
models was performed.
Results: We were able to find models that account for experimental observations from every original study, but do
not require all 5 hypotheses to be implemented. Surprisingly, all hypotheses were in agreement with all tested data
gathered from the different studies and PI3K was identified as an essential regulator of mTORC2.
Conclusion: The results and additional data suggest that more than one regulator is necessary to explain the
behavior of mTORC2. Finally, this study proposes a new experiment to validate mTORC1 as second essential regulator.
Keywords: Logical modeling, mTORC2 regulation, Cancer signaling
Background
The mammalian target of rapamycin (mTOR) is a
highly conserved kinase across species, from yeast to
humans, playing a central role in coordinating cell growth,
metabolism and survival of the cell [1]. In the cell, mTOR
acts as a signal integrator through two distinct complexes,
mTORC1 and mTORC2, each phosphorylating distinct
sets of substrates upon stimulation by growth factors,
nutrients, hormones, stress, and other stimuli [2]. Dys-
regulation in these processes was found to be present in
many cancer types, therefore understanding the structure
and dynamics of mTOR regulation is of high interest [3, 4].
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Although mTORC1 was the main focus of most studies
so far, recent studies found mTORC2 playing an impor-
tant role in cancer development, e.g. in HER2/PIK3CA-
hyperactive breast cancer [5]. The development of novel
mTOR kinase inhibitors has already yielded interesting
findings on mTORC1 and mTORC2, but in order to suc-
cessfully apply these drugs in combined therapy, a detailed
understanding of the signaling processes is essential and
not yet achieved [6, 7].
Besides the catalytic mTOR subunit, both complexes
contain mLST8, while Rictor and SIN1 are specific
for mTORC2 and Raptor and Pras40 are specific for
mTORC1. Upon stimulation, receptor tyrosin kinases
(RTK) activate mTORC1 mainly via PI3K-mediated phos-
phorylation of Akt (see Fig. 1). In detail, the activated
receptor binds and activates IRS which recruits PI3K
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Fig. 1 Scheme of PI3K pathway with candidate regulators of mTORC2 colored in green. Insulin and growth-factors activate RTK signaling through
PI3K and the well-known regulation of mTORC1 with negative feedback on IRS-1. The regulation of mTORC2 is unclear
to the plasma membrane. PI3K activates PDK1 binding
PdtIns(3, 4, 5)P3 (PIP_3), which recruits the multi-
functional kinase Akt to the plasma membrane and phos-
phorylates it at T308. This phosphorylation is sufficient to
activate Akt which in turn inhibits one of its targets, the
tuberous sclerosis complex 1/2 (Tsc) [8]. This process acti-
vates the G protein Rheb, which then activates mTORC1
[9]. One main target of mTORC1 is p70S6K, which is able
to phosphorylate IRS. Thereby the binding of IRS to PI3K
is disrupted and PI3K becomes inactive, thus creating a
negative feedback [10]. Upon stimulation with growth fac-
tors, mTORC2 activates AGC kinases (protein kinase A,
G, and C), in particular it phosphorylates Akt at S473 [11].
Moreover, mTORC2was reported to phosphorylate Akt at
T450 at themitochondrial membrane as a protein stabiliz-
ing post-translationmodification. However, this process is
growth-factor independent and not considered here.
Conflicting studies onmTORC2 regulation
In contrast to mTORC1, the processes that control
mTORC2 are uncertain [12]. There are multiple studies
investigating the influence of various kinases from the
PI3K pathway on mTORC2 or components of its com-
plex. Each of these studies is used as one hypothesis in
our investigations: feedback independent regulation via
RTK [13], activation by PI3K [14], positive feedback from
Akt on mTORC2 [15], Tsc dependent regulation [16], and
inhibition by mTORC1 [17].
Hypothesis 1: Feedback independent activation A
feedback independent activation of mTORC2 was pro-
posed by Dalle Pezze et al. [13], where they presented a
data-driven ODE modeling approach investigating three
different models: one model having Tsc as activator, a sec-
ond model with only PI3K as activator and a third model
wheremTORC2 is regulated by an unknown kinase, which
is independent from the negative feedback on PI3K [13].
Here, the authors used experimental design based on sim-
ulations of the models to find perturbation experiments
that are able to distinguish between the different hypothe-
ses. Thereby, the group was able to extract their final
model as a feedback independent activation of mTORC2.
Hypothesis 2: Direct activation by PI3K An activa-
tion of mTORC2 by PI3K was proposed by two different
groups. Gan et al. [14] claimed that it is known that PI3K
via PIP_3 has two effects on Akt. First, it recruits the
kinase to the plasma membrane and phosphorylates the
protein at T308. Secondly, it regulates the S473 phospho-
rylation of Akt via mTORC2, but whether or not it directly
interacts with the complex is unknown [14]. Therefore,
the authors created an Akt mutant which is constantly
bound to the plasma membrane and thereby dissecting
the recruiting effect from PIP_3 from its potential activa-
tion of mTORC2. Although they were able to show that
the regulation via the Akt mutant is still sensitive to PI3K
inhibitors, the exactmechanism could not be clarified [14].
In a recent work by Liu et al. (2015) a regulation of
mTORC2 by PI3K was claimed, where they observed
molecular interactions between SIN1, Akt and PIP_3 [18].
Liu et al. (2015) suggested that SIN1 might act as gate-
keeper inmTORC2, therefore they investigated its mecha-
nistic interaction withmTOR. As a result, the experiments
showed that an interaction of SIN1-PH domain with the
kinase domain of mTOR leads to a suppressed mTOR
activity [18]. Since PH domains are characterized by their
ability to bind PdtInsPns, Liu et al. (2015) tested bind-
ing properties of different PdtInsPns to SIN1-PH. They
showed that PIP_3 binds to the SIN1-PH domain. More-
over, PIP_3 and SIN1 were shown to compete for binding
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with the kinetic domain of mTOR. Therefore Liu et al.
(2015) claim that SIN1 binds mTORC2 blocking its activ-
ity and PIP3 then binds SIN1 to release the inhibition on
mTORC2, then Akt can bind to be phosphorylated.
Hypothesis 3: Akt directly activates mTORC2 caus-
ing a positive feedback Another member of the PI3K
pathway, Akt, was proposed to regulate mTORC2 by two
studies from the James lab [15, 19]. First, Humphrey et al.
presented a quantitative analysis of the insulin signal-
ing network in adipocytes using mass spectrometry-based
proteomics [19]. In particular, they suggested that SIN1
phosphorylation at T86 is insulin sensitive and that this
regulation acts through Akt, due to its timing and Akt
inhibitor response. Moreover, a recent paper from the
same lab by Yang et al. showed the same effect on a molec-
ular level in various cell types [15]. Here, they examined
SIN1 phosphorylation at T86 upon Akt, mTORC1 and
S6K inhibition, showing a reduced phosphorylation level
only for Akt inhibition but not mTORC1 or S6K inhibi-
tion. They conclude that the activation of mTORC2 fol-
lows activation of Akt by T308 phosphorylation, then Akt
phosphorylates SIN1 activating mTORC2, which itself
then phosphorylates Akt at S473 for its full activation [15].
Hypothesis 4: Activation by Tsc2 Huang et al. [16]
found that Tsc2, a component of Tsc, is required for
mTORC2 activity by performing experiments with Tsc
knock-out Mouse Embryonic Fibroblast (MEFs). For var-
ious stimuli they showed that in these cells the phospho-
rylation of Akt at S473 is lacking, but can be recovered
adding a vector that expresses human Tsc2 [16]. Due to
the negative feedback of mTORC1 on PI3K, a decreased
activity of mTORC2 in Tsc2 knock-out cells can also result
from constantly active mTORC1. In the paper, Huang et
al. argue that the effect of the Tsc2 knock-out can be sep-
arated from the feedback by looking at experiments with
mTORC1 inhibition.
Hypothesis 5: Integrity of mTORC2 is regulated by
mTORC1 via SIN1 phosphorylation In direct contra-
diction with the findings of Humphrey and Yang et al.,
Liu et al. (2013) claimed in an earlier paper that S6K or
Akt phosphorylates SIN1 not only at T86 but also at T398
and thereby causes a dissociation of the mTORC2 com-
plex resulting in its inhibition [17]. In this paper, HeLa
cells and MEF cells were stimulated with either insulin or
EGF and treated with various inhibitors mostly rapamycin
but also S6K and Akt inhibitors. Moreover, SIN1 mutants
with T96A and T398A genotype were used to mimic per-
manently non-phosphorylated SIN1 variants as well as
knock outs.
Modeling of uncertain systems
In order to clarify the regulation of mTORC2, we use
mathematical modeling to systematically analyze the pro-
posed hypotheses from the literature. When modeling an
uncertain system, one can either build a model based
on assumptions or build every possible model that arises
from the uncertainty to compare their performance. How-
ever, depending on themodeling formalism building every
possible model can be computationally challenging, e.g.
finding parameters for one ODE model is already a hard
problem usually also rife with uncertainty. Here, we use a
logical modeling workflow [20–22] to create and analyze
possible topologies andmechanisms of biological systems.
This formalism is able to capture qualitative effects of
the interactions by analyzing basic behaviors, which was
shown to deliver valuable results for signaling processes
[23–25]. Other logical modeling approaches that incor-
porate uncertainty are available, e.g. CellNetOpt or an
Answer Set Programing based approach by Videla et al.
being similar to our tool [26, 27]. These tools differ in sev-
eral aspects from our approach. In particular, both meth-
ods train models according to optimality criteria rather
then considering the full set of consistent models, or focus
on steady state responses.
For our approach, available information about the bio-
logical system is collected from literature and represented
in a graph: components as nodes and interactions as
edges. Then, the quality of this information is evaluated,
where highly certain and textbook knowledge is consid-
ered to be essential and uncertain information is con-
sidered to be optional. For our model this means that
interactions arising from essential information are identi-
cal in every model whereas optional interactions can be
present or absent. In the graph, this evaluation is given by
edge labels, such as for an activating interaction the essen-
tial label is + and for an optional edge we define it as not
inhibiting ¬−, which means the edge is either absent in a
model or it is activating.
The model is then formed by defining logical rules for
every component of the graph describing the regulatory
wiring of the incoming edges using logical AND or OR
connections. In case a graph contains an optional edge,
multiple models are build for either not containing that
edge or containing it and then building every possible log-
ical rule with it. Thus, building the set of all models, called
model pool, is a combinatorial problem that grows with
the number of optional edges. By simulating qualitative
behavior of amodel, we can compare the dynamics of each
model to available data in order to find those models that
are consistent with the data while eliminating others from
the pool. Finally, the consistent models can be analyzed
using specialized software in order to eliminate uncer-
tainties and identify trends for further studies (for more
details see “Methods” section).
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Here, we identified 5 hypotheses for the regulation of
mTORC2, which are translated to uncertain edges on
mTORC2 and give rise to themodel pool. Testing this pool
for data from the original studies posing these hypotheses
markedly reduced the size of the model pool. By analyzing
this pool, we found that none of the hypotheses contradict
the data from other studies, even though they intended to
support a different hypothesis. Also, we found that some
interactions are redundant and therefore not necessary
for the model. Thus, we identified models with less than
five edges that are valid for data sets from all original
studies. Since biology is expected to be sparse, we sought
the simplest mechanism by looking at minimal models.
Such a minimal model is having PI3K as the only regula-
tor of mTORC2, moreover we found this regulation to be
essential.
The formalism allows for easy implementation of in sil-
ico experiments, which in turn can be exploited for wetlab
experimental design. Formal analysis indicates that the
feedback is a crucial factor for obtaining informative data.
To illustrate this point, we propose and implement in sil-
ico a simple experiment that blocks the feedback. Exploit-
ing the resulting data for the pool analysis shows that this
experiment could validate mTORC1 as a second essen-
tial regulator additionally to PI3K, which is supported by
recent publications.
Results
Model building from literature
For building a model of the mTORC2 regulation by sig-
naling processes, we only included studies investigating
direct interactions with the complex, excluding metabolic
effects. We reduced the biological system to those com-
ponents that are measured or perturbed in the studies
we examined. The interactions between these compo-
nents and their labels are also deduced from literature,
where interactions that are widely accepted to be common
knowledge are set to mandatory and uncertain interac-
tions as optional (for more details on the formalism see
“Methods” section). Here, the regulations within the PI3K
pathway and the negative feedback are assumed to be
known. However, the regulation of mTORC2 is unclear,
thus all candidate interactions from RTK, PI3K, Akt, Tsc
and mTORC1 are set as optional.
The regulations of the components are defined as func-
tions according to the edge labels. For components that
only have one regulator, the function can be directly
derived from the edge label. For PI3K and Akt, the logical
connection between the regulators needs to be deduced
from biological knowledge. PI3K is activated by RTK and
inhibited by IRS, where IRS binds and thereby blocks
PI3K from interaction with other components including
RTK. Thus, the logical connection is AND, since PI3K
can only be active if RTK is active and IRS is not. The
interactions from PI3K and mTORC2 on AKT are con-
nected with a logical OR, because both are able to activate
the component independently [8].
The interaction graph of the model is shown in Fig. 2,
with the logical functions on the left side and a list of the
regulators with references on the right. For the regulation
of mTORC2 various hypotheses were published, which
can be summarized as 5 candidate regulations:
1. RTK indirectly regulates mTORC2, thus the
regulation is insensitive to the negative feedback of
mTORC1 on PI3K [13]. For our model, we included
an activating edge from RTK to mTORC2 with the
label not inhibiting.
2. PI3K directly activates mTORC2 [14, 18], thus we
include an activating edge from PI3K to mTORC2
labeled as not inhibiting in our model as Hypothesis 2.
3. Akt activates mTORC2 by phosphorylation of SIN1
at T86 [15, 19]. For our model, Hypothesis 3 is a not
inhibiting edge from Akt to mTORC2.
4. Tsc is required for mTORC2 activity shown in Tsc2
knock-out cells [16], therefore we included this
Fig. 2 Interaction graph and overview of hypothesis for mTORC2
regulation. Black lines indicate edges that are mandatory and green
lines have edge labels allowing for uncertainty annotated with their
respective edge label. a List of logical functions for components with
known regulation, where the notation signifies a logical AND as ∧, OR
as ∨ and negation as ¬. b List of candidate regulators for mTORC2 in
the literature
Thobe et al. Cell Communication and Signaling  (2017) 15:6 Page 5 of 15
observation as Hypothesis 4 as a not inhibiting edge
from Tsc to mTORC2.
5. A phosphorylation of SIN1 by S6K causes a
disintegration of the complex [17], thus we included
an inhibiting edge from mTORC1 on mTORC2 with
the label not activating into our model.
In Fig. 2 these regulations are marked as green lines,
meaning that we do not know whether these connections
are functional. Thus, the logical function for mTORC2
is uncertain and we want to explore all possible models
using the edge labels and known logical rules for the other
components as constraints. For building the model pool,
every topology of possible combinations of the 5 candi-
date edges is created, resulting in 32 topologies. Then,
for every topology all truth tables, representing a logical
function, are generated and subsequently selected for the
pool if they agree with the constraints (for more detail see
[20]). This process is computationally challenging, e.g. for
a component with n optional incoming edges the upper
bound of possible truth tables is 22n . Using the software
Tremppi [21], a model pool of 7581 models is determined.
Discretization of experiments from literature studies
shows redundancy in data
Subsequently, data from the original studies were used
to filter the model pool for those models that are in
agreement with the experimental data. For this aim, we
need to discretize this data to match the logical formal-
ism and encode it to make it accessible for our software.
The discretization method depends on the data type, e.g.
quantitative values or western blot images (for detailed
description see the “Methods” section). Here, we dis-
cretized data from each study which was included as a
hypothesis for this investigation. Since the original studies
have different levels of detail and used different methods
to prove their hypothesis, we can only include a subset of
the performed experiments here (see Discussion for more
details). However, even though the papers claim different
results, we found thatmany performed the same or similar
experiments from a qualitative perspective.
For example, the time series measurements upon insulin
stimulation were done by five out of seven studies. The
resulting discretized sequences were partially redundant
with data sets of other experiments (see Table 1). Similarly,
an experiment with mTORC1 inhibition and insulin stim-
ulation was done by four groups, either using rapamycin
or shRNA against Raptor. After discretizing the data, all
studies observed active PI3K and mTORC2 measured by
Akt phosphorylation. The effect of PI3K inhibition on
mTORC2 activation was studied by four groups, where
inhibitors like Wortmannin or LY294002 were used to
directly block PI3K or the activating connection to Akt
was impeded by inhibiting PDK1. These experiments con-
sistently led to inactive mTORC1 and mTORC2 across
all studies. Three studies investigated the activity of
mTORC2 upon insulin stimulation in Tsc knock out/down
MEF cells with equivalent results.
For our study, we included the most comprehensive
data set for our analysis and excluded redundant informa-
tion.These comparisons reduced the number of data sets
to be tested to five different experiments shown in Table 2.
Note that this observation indicates a certain reliability
of the data, since even though the experiments were per-
formed by different groups with different aims and setups,
their qualitative interpretation is comparable.
In order to compare the data with the model dynam-
ics efficiently, the discretized data needs to be encoded
in temporal logics, here we used Computation Tree Logic
(CTL). For this encoding, each measurement is defined as
a state of the system that needs to be reached from the
previous measurement. Additionally, the temporal inter-
pretation of a state needs to be defined, meaning that the
state can be an initial state, a transient state or a steady
state (see “Methods” section). In the following, the dis-
cretized and encoded experimental data included in this
study is described in brief.
We used time-course measurements as well as knock
down experiments from the study of Dalle Pezze et al. [13].
In detail, time series measurements of insulin stimulated
HeLa cells for various proteins were done (see Fig. 4 in
[13]). Here, we included data of the following components
Table 1 Redundancy in experiments across different studies
PI3K inhibition mTORC1 inhibition Tsc knock out Insulin stimulation
Dalle Pezze et al. Fig. 8a Fig. 7a Fig. 6a, b Fig. 4a, b
Gan et al. Fig. 2a
Liu et al. (2015) Fig. 3d Fig. 2d
Humphrey et al. Fig. 6b
Yang et al. Fig. 4c Fig. 4a, b Fig. 4b
Huang et al. Fig. 3a Fig. 1a Fig. 3
Liu et al. (2013) Fig. 1a Fig. S4j
The columns show types of experiments that were done in various studies yielding in matching qualitative behavior after discretization (data not shown)
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Table 2 Data processing for logical analysis by discretization and formal encoding as CTL formula
Property name: T_4B
measured 0 5 10 20 30 120 readout CTL:





Akt-pS 0 1 1 1 1 0 mTORC2 EF(RTK=1&PI3K=0&mTORC2=1&mTORC1=0&IRS=1&
IRS-pS 0 0 1 0 1 1 IRS EF(RTK=1&PI3K=1&mTORC2=1&mTORC1=0&IRS=0&
p70-S6K 0 0 0 1 1 1 mTORC1 EF(RTK=1&PI3K=1&mTORC2=1&mTORC1=1&IRS=1&




measured 45 100 180 readout CTL:




EF(mTORC2=1 & PI3K=1 & Delta=0)
Akt-pS 1 1 1 mTORC2 Initial State: RTK=1,
Insulin 1 1 1 RTK Fixed: mTORC1=0
T_8A
measured 30 50 readout CTL:




EF(mTORC2=0 & mTORC1=0 & Delta=0)
p70-S6K 0 0 mTORC1 Initial State: RTK=1
Insulin 1 1 RTK Fixed: PI3K=0
M_1A





EF(mTORC2=0 & mTORC1=1 & Delta=0)
S6K-pT 1 mTORC1 Initial State: RTK=1
Insulin 1 RTK Fixed: Tsc=0
M_3BC





EF(mTORC2=0 & mTORC1=1 & Delta=0)
S6K-pT 1 mTORC1 Initial State: RTK=1
Insulin 1 RTK Fixed: Tsc=0, IRS=1
M_3BC2






S6K-pT 0 mTORC1 Initial State: RTK=1
Insulin 1 RTK Fixed: Tsc=0, mTORC1=0
The tables show measured components, time points in minutes and readout. For the CTL formulas the settings are given, which is the measurements, the initial state and
fixed components. If no measurement at time point 0 is available, the set up of the experiment is used , e.g. stimulation of the receptor. The fixed components encode a
knock down/out in that component. Additionally, the option Delta=0 encodes a steady-state (more details see “Methods” section). T_4B Time series data of selected
components from Fig. 4b in [13]. The table shows measurements that were discretized by mean value. CTL formula uses time point 0 as initial state and further data points as
sequence. T_7A Perturbation experiment with knock down of mTORC1 component Raptor leads to sustained Akt activity, encoded as fixpoint in the CTL formula with fixed
mTORC1 (Fig. 7 in [13]). T_8A PI3K inhibition by Wortmannin causes complete inhibition of all pathway components including Akt and mTORC1 target p70-S6K (Fig. 8 in [13]).
The Data in encoded as a fixpoint with fixed PI3K.M_1A Data from Huang et al., where Tsc2-/- cells show inactive mTORC1 and mTORC2, encoded as fixpoint with fixed Tsc
(Fig. 1 in [16]).M_3BC andM_3BC2 Combined data sets from two experiments for showing the independence of Tsc effect on mTORC2 and negative feedback (Fig. 3 in
[16]), encoded as fixpoint with Tsc and IRS fixed
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in our model: Akt-pT, Akt-pS, IRS-pS, and S6K-pT (see
Table 2 T_4B). The data was discretized by mean value,
then assigned to its designated readout. Here, RTK was
added to the data set as a measured component to encode
the stimulation over time. Finally, the sequence is encoded
as CTL shown in Table 2 T_4B.
We also included data from the perturbation exper-
iments from Dalle Pezze et al., where mTORC1 was
inhibited by shRNA against Raptor in HeLa cells and the
phosphorylation levels of Akt were measured 45 and 100
minutes after insulin stimulation (see Fig. 7 in [13]). The
corresponding CTL formula in Table 2 T_7A contains
RTK as active in the initial state due to insulin stimula-
tion and the knock down of Raptor is encoded as setting
the logical equation of mTORC1 to 0. We call this a fixed
component. Moreover, we assume the signaling process to
be in steady state, since there is no change even after 180
minutes observable.
The effect of PI3K inhibition on mTORC2 activation
was studied by treating HeLa cells with different con-
centrations of the inhibitor Wortmannin, which directly
blocks PI3K (see Fig. 8 in [13]). After stimulating the cells
with insulin, inactive mTORC1 and mTORC2 was mea-
sured after 30 and 50 minutes, where the effect intensified
with increasing concentration. The resulting CTL formula
T_8A is shown in Table 1, where PI3K is fixed to zero
due to the inhibition and the dynamics are assumed to be
a fixpoint, since the behavior was stable over both time
points.
Huang et al. used Tsc2−/− Mef cells and treated them
with various stimuli for 30 minutes to measured Akt-pS as
well as S6K-pT (see Fig. 1a in [16]). To encode the knock
out, Tsc is fixed to zero and the stimulation is encoded
as active RTK. These experiments lead to active mTORC1
but inactive mTORC2 after e.g. insulin stimulation, result-
ing in the CTL formula M_1A (see Table 2). The authors
expected this behavior to be stable over time, therefore we
encoded this measurement as a fixpoint.
Also, Huang et al. investigated the influence of the neg-
ative feedback on the signaling process. In Fig. 3b and c
in [16], Tsc2−/− Mef cells were treated with insulin for
15 minutes and Akt-pS, IRS and its binding to PI3K was
measured. In the experiment, the phosphorylation of IRS
by mTORC1 was measured showing a hyperphosphoryla-
tion due to the knock-out in the mTORC1 inhibitor Tsc.
In this hyperphosphorylated state of IRS the binding with
RTK and PI3K disintegrates and PI3K becomes inactive,
thus IRS is fixed to 1 in the CTL formula M_3BC. Addi-
tionally, they claimed that the impaired mTORC2 activity
in Tsc2−/− Mef cells was not caused by a constantly acti-
vated feedback through mTORC1 on PI3K [16]. They
argued that the mTORC2 activity should be rescued upon
mTORC1 inhibition causing a deactivation of the feed-
back, if PI3K would be the only activator. To show this,
mTORC1 was knocked down using siRNA against Raptor
and the cells were stimulated with insulin for 15 minutes.
In Fig. 3b and c in [16], the binding of IRS to PI3K was
restored, but the mTORC2 complex did not show any
kinetic activity. For the CTL formula M_3BC2, Tsc and
mTORC1 are fixed to zero. The data sets M_3BC/2 are
examined separated from the other experiments, because
15 min measurements are usually not sufficient to assume
a fixpoint. However, we are especially interested in the
effect of the feedback on the dynamics of the models.
Additionally to the experimental data, we assume
that without any stimulus the signaling system should
reach an inactive steady state. This steady state rep-
resents the quiescence state of the biological system
that is supposed to be fulfilled for the highly reg-
ulated growth-factor signaling in healthy tissue. For-
mally encoded, this means Triv_FP: EF(mTORC2=0 &
Delta=0), Initial State: RTK=0.
Filtering for data reduced size of model pool Based on
the data, we were able to fully determine the regulation
for every component in the model only the regulation of
mTORC2 remains to be elucidated (Fig. 2). Combining
all possible logical functions from 5 optional edges under
the given constraints gives rise to 7581 models, the set of
which we call initial pool. In the next step, this pool is
filtered by applying CTL formulas derived from the data
in Table 2 as restrictions on the model pool using model
checking. Thereby, the trajectories of each model are
matched with the sequences defined by the CTL formulas
and the model is rejected in case of a mismatch.
As a result, each CTL formula reduces the initial pool
to subpools of various sizes (see Table 3). Finally, the
intersection of these subpools creates different reduced
pools, which contains only those models that are valid for
all CTLs. The main reduced pool we obtained is called
Red.pool having 944 models that are true for all data sets
excluding M_3BC and M_3BC2. If we now apply addi-
tional CTL formulas to the Red.pool, the intersection with
M_3BC does not result in a further reduction in the pool
size meaning that all models in the Red.pool are valid for
this data set. However, the opposite is true for M_3BC2,
where no model from the Red.pool agrees with this for-
mula. We will discuss this point further in the following
section.
Model pool analysis
In oder to gain information about the influence of
the applied data on the pool, we need to analyze the
pools. Although filtering for the data reduced their size
markedly, they are still too large to analyze them by hand.
Therefore, we employ a statistical approach first, following
up with an exact analysis.
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Table 3 Applying CTL formulas to the pool reduced its size markedly
CTL: / Triv_Fp T_4B T_7A T_8A M_1A M_3BC M_3BC2 ExpD1 ExpD2
# models: 7581 5573 5202 7413 2008 7413 5573 168 2008 5573
intersection: Red.pool: 944 944 0 310 634
Red.pool is the intersection of all data sets except M_3BC and M_3BC2. M_3BC shows no further reduction on the Red.pool, whereas M_3BC2 has no shared models with the
Red.pool. On the right, the experimental design formulas are shown, which both show a further reduction on the selected pool
Strong influence of PI3K regulation shown in
statistical analysis In a first step, we evaluated both the
reduced and the initial pool statistically using the soft-
ware Tremppi [28], which is an efficient model checker
tool developed for these applications. In the statistical
analysis, we want to identify edges that are enriched or
under-represented in the filtered pool in comparison to
the initial pool, since this difference is strongly implied
by the data [22]. For this purpose, two measures are
estimated: (i) frequency of an edge and (ii) its impact.
For (i), the frequency of appearance of an edge across the
pool is counted and divided by the pool size. The higher
the frequency, the more models require the considered
edge to be present. Then in (ii) the impact of the regulator
on its target is calculated as correlation coefficient in
the range [-1,1] between source and target component
in every model, where -1 means fully inhibiting, 1 is
fully activating and 0 means no influence. The impact is
the averaged correlation across the pool. A high impact
indicates that the regulator across all models in the pool
has a strong influence on the behavior of the target, since
their states are highly correlated.
For our analysis, we evaluated the initial pool and the
Red.pool, then calculated the differences between them by
subtraction. In Tremppi, these differences can be visual-
ized as a graph shown in Fig. 3. Here a graph illustrates
the difference between the Red.pool and the initial pool,
where an increase in frequency and impact for the reg-
ulation of mTORC2 by PI3K can be observed (Fig. 3).
Moreover, the Red.pool contains less models with a reg-
ulation by RTK and Tsc than the initial pool and the
impact of these edges is reduced. Note that the frequency
and correlation differences are very small, since for fre-
quency the maximum value is 0.02 in possible range of
[0,1] and the correlation ranges between -0.09 and 0.17
with a possible range of [-2,2]. This means that the differ-
ence in frequency and impact between the pools is small,
which can be explained as an artifact of the modeling pro-
cess (more information in Discussion section). In order to
resolve these results further, we examine the composition
of the pools explicitly.
Minimal model corresponds to Hypothesis 2 Despite
the fact that the statistical evaluation is able to give us
Fig. 3 PI3K regulation on mTORC2 is present in every filtered model, but not in original pool. Statistical analysis of the reduced pool and initial pool
for frequency F and impact I (correlation of components) was created with Tremppi and the graph shows the difference (reduced - full) for the
Red.pool. PI3K regulation of mTORC2 is overrepresented in the reduced pool in both frequency and impact compared to the initial pool. The
regulation by RTK and Tsc is less frequent in the filtered pool than in the full shown by dashed lines, yellow dotted lines show identical frequency and
impact in both pools. The table shows the classification of all 994 models in the Red.pool according to the following features: Edges in the model,
the data sets, and active hypotheses. Size gives the number of models in the class and the percentage of this class in the pool
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important information about the changes in the pool
composition, it does not give information about explicit
models. Thus, we used a second model checking tool
called TomClass [29], which groups the models into
classes according to defined features. Since we are inter-
ested in the topology of models and their dynamical
behavior, we defined the features as: number of edges, val-
idation for the CTLs, and present hypotheses. Then all
models that are equal with respect to these features are
grouped in one class, which in our setup means, mod-
els in one class share the same topology and behavior
towards the checked CTLs, and only differ in their logical
equation.
Figure 3 shows all 994 models in the Red.pool con-
taining models with less than 5 edges. However, adding
up the size of classes with 5 edges, it becomes clear
that more than 90% of the models contain 5 edges as is
expected, since the more regulators are available the eas-
ier the model can be fitted to the data. Moreover, we can
say that all hypotheses are in agreement with the data,
since every hypothesis is present in at least one model,
even when only considering the models with less than 5
edges. In detail, 3 edges are necessary for all hypotheses
to be present, for 2 edges models with pairwise combina-
tions of mTORC1, RTK and PI3K are observed and only
PI3K appears as possible single regulator. Thus, the min-
imal model, meaning the lowest numbers of mTORC2
regulators, corresponds to Hypothesis 2. Surprisingly, this
edge is present in every model in the pool and there-
fore seems to be essential for the model dynamics to
match the data. Thus, although all hypotheses are able
to match the data, not all of them are necessary to
be present.
Analysis of additional data set causes conflict Wewere
especially interested in a data set by Huang et al., since
they claimed to show an effect on mTORC2 that can
be separated from the feedback affecting IRS and PI3K
[16]. Two CTL formulas, M_3BC and M_3BC2, were
extracted from this data set and applied both first as
transient measurements. As a result, both formulas were
in agreement with every model in the pool, since reaching
one state is too easy for these very similar models in the
pool (data not shown). Although the measurement time
point was 15 minutes and therefore usually does not qual-
ify for a steady state assumption, we tested the data as
hypothetical fixpoints. Then, M_3BC was met by many
models in the pool and the intersection with the Red.pool
did not result in a further reduction of the pool (see
Table 3).
However, the second formula M_3BC2 led to a strong
reduction in the pool size with only 169 out of 7581 being
in agreement. When calculating the intersection with the
Red.pool, the result is an empty set, caused by a direct
conflict with T_7A. Therefore, our model does not sup-
port the conclusions drawn in the original paper (we will
resolve this in more depth in the Discussion).
Experimental design
The idea of the experiment in Huang et al. to disrupt
the feedback for dissecting the processes in the cascade
and their effect on mTORC2 led us to propose a new
experiment. For this experiment, we want to eliminate the
negative feedback, e.g. by mutating the target phosphory-
lation side in IRS such that IRS maintains its function as
mediator of the signal from RTK to PI3K, but S6K can-
not phosphorylate and inhibit PI3K. In such a system, a
standard experiment would be to stimulate the receptor
with insulin and measure the mTORC2 activity by AktpS
levels.
From a modeling perspective, steady state measure-
ments more effectively restrict the pool than transient
measurements, therefore AktpS should be measured at
multiple time points to ensure stability. The possible
outcome of this experiment would be active or inac-
tive mTORC2. To test this behavior on the Red.pool, we
formulated these scenarios as CTL formula:
• ExpD1: EF(mTORC2=0 & Delta=0),
Initial State: RTK=1, Fix: IRS=0,
• ExpD2: EF(mTORC2=1 & Delta=0),
Initial State: RTK=1, Fix: IRS=0.
Experiments split the pool for mTORC2 behavior The
CTL formulas split the initial pool as well as the Red.pool
in two groups, showing that every model reaches a fix-
point (Table 3). In both cases, the pool for ExpD1 is
roughly half the size of ExpD2 with 310 to 634 models for
the intersection with the Red.pool, called Red.ExpD1 and
Red.ExpD2 respectively.
In order to further characterize the differences between
these two pools, we analyzed both Red.ExpD1 and
Red.ExpD2 analog to the Red.pool by a statistical and
exact analysis. For Red.ExpD2, the results show no clear
trend towards rejecting or supporting another hypothe-
sis (Fig. 4b). The minimal model with only the essential
PI3K is in agreement with ExpD2, for two regulators only
RTK is possible and for three regulators every hypothesis
is present.
In contrast, the analysis of Red.ExpD1 identifies
mTORC1 as second essential regulator, which is illus-
trated in the graph in Fig. 4. Here, the difference between
Red.ExpD1 and the initial pool shows an increase in fre-
quency and impact for PI3K regulation, but it also displays
a over-representation of mTORC1 inhibition of mTORC2.
Furthermore, RTK is under-represented in the difference
graph and has a negative impact (Fig. 4). In Red.ExpD1,
the minimal model contains PI3K and mTORC1 as dual
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Fig. 4 Experimental design suggests mTORC1 as second regulator of mTORC2. The model pools Red.ExpD1 and Red.ExpD2 are listed with the same
classification option than Fig. 3 in Table (a) and (b), respectively. Table a shows the 310 models from the Red.pool that are in agreement with
ExpD1, where all models contain PI3K and mTORC1 as essential regulators. The 634 model agreeing with ExpD2 and Red.pool are shown in Table
b and do not show a clear tendency towards a second regulator. The graph shows the difference of the statistical analysis of Red.ExpD1 and the
initial pool, visualizing the over-representation of PI3K and mTORC1 regulation on mTORC2 and an under-representation of RTK
regulators for mTORC2, for three regulators every other
hypothesis is possible (Fig. 4a). Thus, the data set ExpD1
identifies a dual regulation of mTORC2 by PI3K and
mTORC1 proposing an experiment to clarify this point.
Discussion and conclusion
In this study, we used a logical modeling approach to
investigate the uncertain regulation of mTORC2 by PI3K
signaling. We were able to show that PI3K itself is neces-
sary for mTORC2 activation, but the regulation is likely
to be more complex. By enumerating all possible models
arising from the state of the art literature, we systemat-
ically tested this pool of models for published data and
analyzed the valid subpools. For analyzing these subpools,
we first compared the reduced pools to the initial pool
statistically. We were able to find enriched and under-
represented hypotheses, but with a seemingly rather low
significance.
The explanation for this issue is given by the exact analy-
sis, where we observed that there is a bias towards models
with many edges, i.e. more than 90% of models in the pool
have 5 edges. There are two reasons for this bias: combi-
natorics and overfitting. When building the model pool,
every possible logical expression is generated, where the
number of combinations increases with the number of
optional incoming edges. For a component with 2 regu-
lators, the upper bound of possible truth tables is 222 =
24 and for 5 regulators it is 225 = 236. Also, the more
regulators are allowed in a model the easier it is to pro-
duce complex dynamics, which is a common problem of
overfitting.
More than 90% of the models of the initial and the spe-
cific pools have 5 edges, thus in the statistical analysis the
difference for the frequency is only influenced by a max-
imum of 10% of the models. The impact also is biased by
these models, since the impact automatically is split upon
all regulators leading to a low impact in models with 5
edges. However, having 4 or even 5 kinases regulating one
protein is unlikely. So even low values must be considered
to uncover important trends. These are then validated in
the second exact analysis to explicitly look at the minimal
models of the pools.
In the exact analysis, models are grouped according to
their number of optional edges. The analysis revealed that
none of the hypotheses can be rejected, but require mul-
tiple edges to explain all data (see Fig. 3). On one hand
this fact is surprising, because the original studies claimed
different hypotheses for the mTORC2 regulation. On the
other hand, the models are very similar and the data we
used for filtering the pool coincided with experiments
from other studies after discretizing, thus discriminating
between the models is hard.
Issue of selecting experimental data from studies We
only used a subset of the performed experiments, which
are not necessarily the most weighty arguments in the
studies. Here, we examined basic qualitative effects which
cannot capture observations from experiments includ-
ing specific manipulations of single components, such
as mutating a phosphorylation site, or dose-dependent
effects. For example, most data of Gan et al. contain an
Akt mutant bound to the membrane which cannot be
Thobe et al. Cell Communication and Signaling  (2017) 15:6 Page 11 of 15
represented in our system without changing the model.
Moreover, the level of detail varies among the studies,
such that we selected a level of abstraction shared by all
studies, e.g. we cannot include experiments with mutated
SIN1, since we cannot represent a partial knock-down of
mTORC2.
The experimental setups between the studies differ,
from cell types to treatments and methods. Most experi-
ments used insulin as stimulus whereas the other studies
used EGF. A very interesting data set from Liu et al.
(2013) showed a transient deactivation of mTORC2 for
EGF on a small time-scale (0 to 60 mins) (Fig. 3d in
[17]), but for insulin this effect was only observable on
a large-time scale (> 60 mins) (Fig. 3b in [17]). For such
long time-scales it is questionable whether the observed
effect is caused by signaling processes or might involve
other processes outside the model boundaries. Also, EGF
stimulation mainly activates the MAPK cascade, which is
known to have crosstalk effects on PI3K signaling [30].
In order to maintain a minimum level of comparability
we do not use data with EGF stimulus. Nevertheless, the
redundancy in the qualitative behavior in the experiments
we observed in Table 1 affirms the comparability of the
selected data sets.
Another data set we found to be interesting is from the
study of Huang et al., which claimed to show a PI3K-
independent effect on mTORC2 [16]. Here, the setup and
the measured components fitted our model, so we build
two different CTL formulas, M_3BC and M_3BC2, for
two observations. However, the issue with this data set
was that it is a single measurement after 15 minutes of
stimulation, thus it is not a steady state measurement. In
general, many modeling formalisms require a steady state
assumption. Although we are able to test both transient
states and fixpoints, testing the reachability of one tran-
sient state is easy to fulfill by the models, thus every model
was valid for the transient version. For this reason, we also
tested both data sets also as hypothetical fixpoints of the
system.
Comparison to original studies The analysis in Fig. 3
revealed that PI3K is an essential regulator across all mod-
els in the filtered pools, which matches the results of
Hypothesis 2 by Gan et al. even though we did not use any
data from that study directly. Also, this finding supports
a recent study from Yang et al. [15], where they sug-
gested PIP_3 to act as a scaffold protein for the interaction
between mTORC2 and Akt.
Comparing our results with the paper of Dalle Pezze
et al., we sought for qualitative similarities and differences
between the studies, since their investigations partially
overlap with our studies. Since we included their final
model as Hypothesis 1, we can say that our results do
not rule out the existence of Hypothesis 1. In particular,
the data sets from Dalle Pezze et al. T_4B, T_7A and
T_8A do not exclude Hypothesis 1, thus there is no
direct contradiction between the studies. Also their data
sets have a large overlap with observations from other
papers (see Table 1). However, we only used a sub-
set of their data, since they measured the activity of
mTORC2 by the phosphorylation of mTOR at S2481, for
which there is a discussion on whether it is a unique
read-out for the activity of the complex [31–34]. Also,
for fitting the models to the data, Dalle Pezze et al.
added an unknown kinase, which is assumed to also
phosphorylate Akt at S473 and thereby could substitute
mTORC2.
Another interesting aspect is that Dalle Pezze et al. iden-
tified a PI3K variant as mTORC2 regulator, because it is
sensitive to Wortmannin, but cannot be PI3K itself due
to insensitivity to the negative feedback [13, 35]. This
insensitivity was observed in a knock-down experiment
for Raptor, where the phosphorylation of mTORC2 did
not decrease upon feedback disruption. However, Raptor
knock-down deactivates mTORC1, thus it also disrupts a
potential inhibition by S6K on mTORC2. Therefore, our
results propose an alternative solution for the PI3K variant
by having PI3K and another second regulator. Conse-
quently, it would be very interesting to build an ODE
model to be able to directly compare our models to Dalle
Pezze et al. and to include quantitative information into
the study.
Finally, the study of Huang et al. tested the behavior of
mTORC2 in Tsc2−/− Mef cells, where we selected three
data sets. M_1A was the basic observation showing an
impaired mTORC2 activity for the knock out, which was
in agreement with almost all models in the initial pool (see
Table 3). The data sets, M_3BC and M_3BC2, were not
included in the Red.pool, but tested separately. The first
formula, M_3BC, was in agreement with Red.pool show-
ing that there is nomore additional information contained
in that data. The second formula,M_3BC2, which was the
main observation of Huang et al., resulted in no intersec-
tion with the Red.pool since it directly conflicts with the
formula T_7A.
In the experiment, they tested whether an inhibition of
mTORC1 can recover the activity of PI3K on mTORC2,
since it deactivates the negative feedback. Huang et al.
argue that this recovery was not observed, thus they con-
clude that PI3K cannot solely regulate mTORC2. For this
purpose, a lot of perturbations were done, Tsc knock
out, Raptor knock down, stimulation, but all these actions
directly affect a possible regulator of mTORC2, there-
fore the expressiveness of the data is limited. To address
this issue, we wanted to find an experiment that does
not manipulate any of the hypothesized regulators of
mTORC2, but gives more information about the feedback
independent processes.
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Identification of regulatory mechanisms requires
deactivation of feedback There are two major reasons,
why the exact regulation of mTORC2 by the PI3K pathway
is hard to identify: (i) the candidates are within one signal-
ing cascade and (ii) the negative feedback from mTORC1
on PI3K. From the first fact the problem of very short time
windows arises, where a kinase becomes active without
activating its downstream target, which is also a kinase.
Producing data that is able to dissect the activity of kinases
in a chain reaction is hard. A possible solution is to block
the cascade at different levels using inhibitors as shown in
Table 1, but due to the negative feedback this treatment
affects all components in the pathway.
For this reason, we proposed an experiment, where
the target phosphorylation sites of the negative feedback
on IRS are mutated. In detail, S302, S307 and S632 are
causing a reduced signaling through PI3K when phospho-
rylated [36], therefore these serine residues would need
to be substituted to e.g. alanine. When stimulating these
mutants with insulin, we predicted two different out-
comes for mTORC2, which splits the model pool in two
groups for active and inactive mTORC2 in steady state.
Analyzing the resulting model pools that agree with the
data from the first analysis in the Red.pool, we found
no clear pattern for Red.ExpD2 having active mTORC2
(Fig. 4b). In contrast, Red.ExpD2 shows mTORC1 as a
second essential regulator.
The edge from mTORC1 was reported by Liu et al. in
form of a dual phosphorylation at Thr 86 and Thr 398
of the mTORC2 component SIN1. Whether or not these
phosphorylations lead to mTORC2 inhibition [17] or for
Thr 86 to activation by Akt as claimed by Humphrey et al.
[19] is unclear, due to conflict of data [37]. Since Akt also
regulates mTORC1, it remains to be clarified whether this
effect is direct or indirect. Also, further studies on the
exact mechanism through which modifications of SIN1
affect the mTORC2 activity are necessary [37]. Still, the
modifications of SIN1 suggest that a regulation by PI3K
alone might not be realistic.
Moreover, in a recent summary Yuan et al. [38] pro-
pose a dual regulation of mTORC2, with PIP_3 as scaffold
and recruiter as well as S6K as inhibitor, which matches
our result from the experimental design pool Red.ExpD2.
This finding is also supported by a recent study in C2C12
myoblasts using ODE modeling, where a regulation by
PIP3 and S6K is proposed [39].
These considerations show that a potentially interest-
ing next step could be to construct more detailed models
in terms of modeling formalism or resolution of compo-
nents, like mTORC2, to increase comparability and more
fully exploit the available data. Such a study could lift our
qualitative results to a more quantitative understanding of
the mechanism of regulation of mTORC2.
Methods
In this paper, an approach for systematically analyz-
ing uncertain biological systems by logical modeling is
used. For this aim, background on workflow, formalism
and tools are given as well as information about data
processing.
Modeling uncertain systems
In the approach, bottom-up model building is used to
collect all available information about the system in a
generic model pool, which is subsequently reduced by
testing consistency with data and analyzed for properties
(see Fig. 5). In detail, all known and uncertain infor-
mation about interactions and regulatory mechanisms
is collected. Then, the topology of the model is repre-
sented as a graph with known edges labeled as mandatory
and uncertain edges as optional as well as the nature of
the interaction being positive or negative. The combi-
nations of all optional edges and all possible regulatory
mechanisms between them give rise to the generic model
pool.
The generic model pool might contain models that are
not consistent with data from literature studies. There-
fore, this data is formalized and compared with the
dynamical behavior of every model in the pool. This pro-
cess can be computationally expensive, since the number
of models can quickly add up to thousands of models. For
this reason, a tailored model checking software for effi-
cient analysis is employed, which filters and evaluates the
specific pool, i.e. Tremppi [21] and TomClass [20].
Fig. 5Workflow for modeling approach. First a generic model pool is created from all available information including uncertainty. Then the pool is
filtered for data to find specific subpools, which can be analyzed for new properties
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Background on logical modeling In this paper, Boolean
networks are used, where components can adopt the value
0 for inactive and 1 for active state. The topology of a
regulatory system is described as a directed graph R =
{V ,E, l}, where the components V = {1, . . . , n} are repre-
sented as nodes, the interactions E ⊆ VxV are represented
as edges and marked with edge labels l : E → L adapted
to the definition from [20]. L is a set of formulas with +
for activating and − for inhibiting edge sign, describing
the effect of the regulator through that edge on its target.
Here, we assign the label + or− to edges of known inter-
action from literature that were always observable with
an activating or inhibiting effect, respectively. The label
¬ + (¬−) is assigned to uncertain edges meaning there
were contradicting studies in literature showing inhibiting
(activating), but in other studies no effect.
Then for each component a function f : Bn → B =
{0, 1} is defined that specifies the impact of all regula-
tors on its target according to the edges labels (more
details see [20]). In case there is more than one regula-
tor controlling a component, logical operators define the
connection between them, i.e. ∧ for logical AND connec-
tion, ∨ for logical OR and ¬ for logical negation. Finally,
a model contains one unique function for every compo-
nent. Since some components have uncertainty in their
edge labels and regulatory mechanisms, there exists more
than one possible function. Thus, every combination of
functions across all components give rise to the model
pool.
A system stateX = (xv) ∈ Bn describes the value of each
component v ∈ V of a model. Then, the dynamical behav-
ior is derived from by the functions f using an update
to define the transitions between states. Here, we employ
an asynchronous update to the functions [40], where only
one component is changed at a time, which usually results
in non-deterministic behavior but includes good matches
for biological behavior.
Discretization and formal encoding of data In order
to apply constraints from data to reduce and validate a
model pool, the data is discretized to match the logical
formalism. The process of discretization is a strong sim-
plification that comes with a loss of information especially
for quantitative data, but can reduce the effects of noise
in data. However, the qualitative effects, such as activation
or inhibition of a component, as well as high-level behav-
ior, such as stability, are preserved. Therefore, the data is
processed in two steps: (i) discretization of the data and
assignment to the designated readout component, and (ii)
formalization of temporal observation such as time series
data.
(i) For discretizing data points into two states, a thresh-
old needs to be defined. In case there is quantitative
information available, different methods can be applied
to find a threshold, such as mean or median [41]. For
qualitative data, measurements are usually interpreted
relative to a control measurement. If a measurement
is ambiguous, it is excluded from the study. Since the
activity of a protein kinase can be measured by the
phosphorylation of its target, we define the presence of
target phosphorylation as readout of the activity of a
component.
(ii) In this study, two different kinds of data sets are
included: time series measurements and single measure-
ments. All measurements need to be interpreted dynam-
ically and encoded so they can be utilized in automated
verification. Here, we use temporal logics CTL for formal-
izing the data. For time series experiments, each measure-
ment represents a transient state of the system, where the
first measurement is called initial state and the following
measurements are represented as a sequence in the order
of time. Each model is then tested for consistency with
the data by checking whether it can generate a path con-
taining the sequence. If measurements do not specify a
unique state, i.e., if data for some components is missing,
all states in agreement with the measured values are con-
sidered. Note that any kind of change between two states
in the sequence is allowed as long as the system manages
to reach the next state at some point. Single measure-
ments are often assumed to be steady states of the system
after e.g. perturbations like knock-outs. A steady state is
described as a stable long term behavior and can be com-
pared with fixpoints of logical models. For denoting the
CTL formulas, the following semantics are used:
• EF(X): is a CTL operator exists finally. This states
that on some path from an initial state the X holds
true at some point.
• Delta=0: states that no change is possible, i.e. we
are in a steady state.
• v=b: where v ∈ V ,b ∈ B states that value of a
component v is set to b.
• Initial state: is a list of boolean constraints on
the values of the components. A state is considered
initial, if all the constraints are satisfied.
• Fixed component: constrains the listed
components to the assigned values for the whole
path. This property allows for modeling knock-outs
and stimuli.
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